Beijing Centergate: China regulator approves clinical trial of BDB tablets for hypertension
Beijing Centergate Technologies said China's NMPA has approved a clinical trial for its unit's BDB tablets, intended for hypertension treatment.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.